Jasmina Bojadzieva

Statistics

Publications

Citations

420

H-Index

Active since

2011

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Korea University

Garvan Institute of Medical Research

Cancer Genetics (United States)

National Cancer Institute

Jasmina Bojadzieva is an author at The University of Texas MD Anderson Cancer Center specializing in li-fraumeni syndrome, oncology, and genetic risk assessment.

ORCID

Publications per year

2011–2021

Publications

Early onset HER2‐positive breast cancer is associated with germline <i>TP53</i> mutations

Amal Melhem‐Bertrandt, Jasmina Bojadzieva, Kaylene Ready et al. · Cancer · 2011 · 138 citations

Medicine, Oncology, Pathology +15

Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants

Adam Bournazos, Lisa G. Riley, Shobhana Bommireddipalli et al. · Genetics in Medicine · 2021 · 104 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic

Jasmina Bojadzieva, Behrang Amini, S. Day et al. · Familial Cancer · 2017 · 51 citations

Medicine, Oncology, Radiology +14

The psychosocial effects of the Li-Fraumeni Education and Early Detection (LEAD) program on individuals with Li-Fraumeni syndrome

Jessica Ross, Jasmina Bojadzieva, Susan K. Peterson et al. · Genetics in Medicine · 2017 · 49 citations · Full text

Education, Educational Psychology, Psychology +14

Estimating <i>TP53</i> Mutation Carrier Probability in Families with Li–Fraumeni Syndrome Using LFSPRO

Gang Peng, Jasmina Bojadzieva, Mandy L. Ballinger et al. · Cancer Epidemiology Biomarkers & Prevention · 2017 · 22 citations

Life Sciences, Genetics, Molecular Genetics +17

1–5 of 9